Giacchetti Gilberta, Ronconi Vanessa, Rilli Silvia, Guerrieri Mario, Turchi Federica, Boscaro Marco
Division of Endocrinology, Azienda Ospedaliero-Universitaria, Ospedali Riuniti Umberto I-GM Lancisi-G Salesi, Università Politecnica delle Marche, Ancona, Italy.
Eur J Endocrinol. 2009 Apr;160(4):639-46. doi: 10.1530/EJE-08-0902. Epub 2009 Jan 8.
Primary aldosteronism (PA) due to aldosterone-producing adenoma (APA) is the most common curable form of secondary hypertension.
In order to evaluate blood pressure outcome after adrenalectomy for APA and to identify new favorable prognostic factors, data from 42 consecutive APA patients who underwent adrenalectomy were collected from 2005 to 2007.
Renin-angiotensin-aldosterone system (upright and postsaline infusion test), serum and urinary electrolytes, office and ambulatory blood pressure monitoring were evaluated at baseline and after a follow-up of 2.7+/-2.2 years. Drug history and adenoma size at morphological evaluation were also collected.
Multiple regression analysis showed that, before surgery, patients with a small adenoma (diameter <20 mm) displayed higher postsaline aldosterone values (P=0.0001), and lower serum potassium levels (P=0.020), than patients with adenoma >20 mm. Before surgery, mineralocorticoid receptor (MR) antagonists were used in patients with small APA in greater percentage than patients with bigger adenomas (64 vs 30% respectively, P=0.037). At follow-up, blood pressure normalized in 63% of the subjects. Recovered patients had a shorter duration of hypertension (P=0.038), and a smaller adenoma size (P=0.035). Receiver operating characteristic curves showed that a duration of hypertension <or=6 years and an APA size <20 mm were the best predictors of blood pressure normalization. Patients with APA <20 mm showed the complete restoration of blood pressure circadian rhythm.
The presence of APA <20 mm, duration of hypertension equal or less than 6 years, and preoperative MR antagonists use are favorable prognostic factors for hypertension recovery after adrenalectomy.
由醛固酮瘤(APA)引起的原发性醛固酮增多症(PA)是继发性高血压最常见的可治愈形式。
为了评估APA患者肾上腺切除术后的血压转归并确定新的有利预后因素,收集了2005年至2007年连续42例行肾上腺切除术的APA患者的数据。
在基线以及2.7±2.2年的随访后,评估肾素-血管紧张素-醛固酮系统(立位及盐水输注试验后)、血清和尿液电解质、诊室血压和动态血压监测。还收集了用药史以及形态学评估时的腺瘤大小。
多元回归分析显示,术前,腺瘤较小(直径<20 mm)的患者与腺瘤>20 mm的患者相比,盐水输注后醛固酮值更高(P = 0.0001),血清钾水平更低(P = 0.020)。术前,小APA患者使用盐皮质激素受体(MR)拮抗剂的比例高于大腺瘤患者(分别为64%和30%,P = 0.037)。随访时,63%的受试者血压恢复正常。血压恢复正常的患者高血压病程较短(P = 0.038),腺瘤较小(P = 0.035)。受试者工作特征曲线显示,高血压病程≤6年和APA大小<20 mm是血压恢复正常的最佳预测指标。APA<20 mm的患者血压昼夜节律完全恢复。
APA<20 mm、高血压病程等于或小于6年以及术前使用MR拮抗剂是肾上腺切除术后高血压恢复的有利预后因素。